CarrieLKitkoMD

PubMed

• 16 citations
  Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
  Rima M Saliba, Amin M Alousi, Joseph Pidala, Mukta Arora, Stephen R Spellman
  Transplantation and Cellular Therapy. 2022-10-01
• 13 citations
  KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial.
  Michael A Pulsipher, Kwang W Ahn, Nancy J Bunin, Nahal Lalefar, Eric Anderson
  Blood. 2022-12-15
• 100 citations
  Vorinostat plus tacrolimus and mycophenolate to prevent graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell ...
  Sung Won Choi, Thomas Braun, Lawrence Chang, James L.M. Ferrara, Attaphol Pawarode
  The Lancet. Oncology. 2014-01-01

Journal Articles

• TNF-inhibition with etanercept for graft versus host disease prevention in high risk HCT: Lower TNFR1 levels correlate with better outcome  
  Choi SW, Stiff P, Cooke K, Ferrara JLM, Braun T, Kitko C, Reddy P, Yanik G, Mineishi S, Paczesny S, Hanauer D, Pawarode A, Peres E, Rodriguez T, Smith S, Levine JE, Biol Blood Marrow Transplant, 1/1/2012
• Impact of immune modulation with in vivo T-cell depletion and myleoablative total body irradiation conditioning on outcome after unrelated donor transplantation for ch...  
  Veys P, Wynn RF, Ahn KW, Samarasinghe S, He W, Bonney D, Craddock J, Cornish J, Davies SM, Dvorak CC, Duerst RE, Gross TG, Kapoor N, Kitko C, Krance RA, Leung W, Lewis..., Blood, 1/1/2012
• Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies  
  Magenau J, Tobai H, Pawarode A, Braun T, Peres E, Reddy P, Kitko C, Choi S, Yanik G, Frame D, Harris A, Erba H, Kujawski L, Elenitoba-Johnson K, Sanks J, Jones D, Pacz..., Blood, 1/1/2011
• Rationale and design of the chronic GVHD cohort study: improving outcomes assessment in chronic GVHD  
  Lee SJ, Flowers ME, Martin PJ, Carpenter P, Hansen J, Chai X, Kurland B, Storer B, Arai S, Johnston L, et al Chronic GVHD Consortium, Biol Blood Marrow Transplant, 1/1/2011
• Join now to see all

Books/Book Chapters

• Expert Clinical Perspective: Controversies and Uncertainties in Diagnosis & Management of Cancer 
  Chapter: Chronic Graft Versus Host Disease. 
  Kitko C and Couriel DEditors: SA Abutalib and M Markman.Wiley-Blackwell Health Sciences Publishers2013
• Extracorporeal Photopheresis 
  Chapter: ECP for the Prevention of Graft-versus-Host Disease. 
  Page 136 - 150Kitko C and Levine JEEditors: H.T. Greinix and R Knobler.De Gruyter Publishers, Vienna, Austria2012
• Chronic graft versus host disease: Interdisciplinary management 
  Chapter: The pathophysiology of acute graft versus host disease. 
  Page 8 - 16Kitko, C. and Ferrara, J.L.M.Editors: G.B. Vogelsang and S.Z. Pavletic.Cambridge University Press, New York, NY2009

Abstracts/Posters

• The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host Disease
  Carrie Kitko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Next Generation Sequence Minimal Residual Disease (NGS-MRD) Predicts Outstanding Event Free Survival (EFS) Regardless of Hematopoietic Cell Transplantation (HCT) Prepa...
  Carrie Kitko, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Prednisone (PDN)/Sirolimus (SRL) compared to PDN/SRL/Calcineurin Inhibitor (CNI) as treatment for chronic graft-versus-host-disease (cGVHD): A randomized phase II stud...
  Carpenter P, Logan B, Lee S, Weisdorf D, Johnston L, Costa L, Kitko C, Bolanos-Meade J, Alousi, A, Horowitz M, Abhyankar S, Waller E, Mendizabal A, Wang Y, Lazaryan A,..., American Society of Blood and Marrow Transplant Meeting, Honolulu, HI, 1/1/2016
• National Institutes of Health (NIH) consensus criteria describe the clinical features of chronic graft-versus-host disease (cGVHD) in children and improve and accuracy...
  Cuvelier G, Nemecek E, Boyer M, Wahlstrom J, Kitko C, Jacobsohn D, Coulter D, Chewning A, McDonald S, Lewis V, Schechter T, Morris J, Halevy A, Schultz K, American Society of Blood and Marrow Transplant Meeting, Honolulu, HI, 1/1/2016
• Phase II Clinical Trial of Etanercept Plus Extracorporeal Photopheresis GVHD Prophylaxis Following Unrelated Donor Transplant.
  Kitko CL, Braun T, Schuler C, Choi SW, Yanik G, Pawarode A, Magenau J, Taylor A, Ferrara JLM, Couriel DR, Levine JE, American Society of Blood and Marrow Transplant Meeting, 1/1/2015
• Fludarabine Combined with Myeloablative Busulfan (FluBu4) Results in Reliable Engraftment and Low Transplant-Related Mortality in Pediatric Patients.
  Harris AC, Braun T, Byersdorfer CA, Choi SW, Connelly JA, Kitko CL, Yanik G, Levine, JE, American Society of Blood and Marrow Transplant Meeting, 1/1/2015
• Routine prophylaxis of Pneumocytisis jirovecii pneumonia in recipients of autologous hematopoietic stem cell transplantation.
  Raser K, McNulty ML, Yanik G, Goldstein SC, Magenau J, Pawarode A, Kitko CL, Hanauer D, Levine J, Couriel DR, American Society of Blood and Marrow Transplant meeting, 1/1/2014
• Allogeneic hematopoietic cell transplant (Allo-HCT) for advanced diffuse large B-cell non-Hodgkin's lymphoma: the University of Michigan experience.
  Pawarode A, Braun T, Magenau J, Choi SW, Kitko CL, Yanik G, Goldstein SC, Couriel DR, American Society of Blood and Marrow Transplant Meeting, Grapevine, TX, 1/1/2014
• Transplant outcomes for children with hypodiploid acute lymphoblastic leukemia: the CIBMTR experience.
  Mehta PA, Eapen M, Zhang MJ, He W, Seber A, Kitko CL, Hale GA, Davies SM, American Society of Blood and Marrow Transplant Meeting, Grapevine, TX, 1/1/2014
• Parametric response mapping as a diagnostic indicator of bronchiolitis obliterans syndrome.
  Galban CJ, Boes JL, Bule M, Meyer CR, Couriel DR, Kitko CL, Ponkowski M, Johnson TD, Lama V, Kazerooni EA, Ross BD, Yanik G, American Society of Blood and Marrow Transplant Meeting, Grapevine, TX, 1/1/2014
• Application of BOS-0 - Potential criteria as a predictor for bronchiolitis obliterans syndrome in allogeneic stem cell transplant patients.
  Abedin S, Yanik GA, Magenau JM, Goldstein SC, Pawarode A, Levine JE, Kitko CL, Couriel DR, American Society of Hematology meeting, 1/1/2013
• Biomarkers of extracellular matrix remodeling in chronic GVHD.
  Kitko CL, Saliba R, Choi SW, Reddy P, Goldstein SC, Magenau J, Pawarode A, Kennel M, Levine JE, White E, Couriel DR, American Society of Blood and Marrow Transplantation meeting, 1/1/2013
• Phase 2 study of allogeneic hematopoietic cell transplant (HCT) following intermediate-intensity fludarabine and busulfan x 4 (FluBu4) conditioning for high-risk or ad...
  Pawarode A, Mineishi S, Braun T, Ferrara JLM, Magenau J, Peres E, Yanik G, Reddy P, Levine JE, Choi SW, Kitko CL, Harris AC, Connelly JA, Goldstein SC, Couriel DR, American Society of Blood and Marrow Transplantation meeting, 1/1/2013
• Non-relapse mortality in chronic graft versus host disease: Risk factors at onset and response to treatment.
  Kitko C, Saliba R, Paczesny S, Kennel M, Choi S, Reddy P, Levine J, Couriel DR, American Society of Blood and Marrow Transplantation meeting, 1/1/2013
• prospective study of allogeneic transplant for older patients with acute m leukemia (AML) indicates that unrelated donor transplants are as efficacious as related dono...
  Yanik G, Magenau J, Goldstein SC, Pawarode A, Talpaz M, Levine J, Choi S, Kitko CL, Couriel DR, American Society of Blood and Marrow Transplantation meeting, 1/1/2013
• Impact of dose intensification of FluBu2 to FluBu4 on transplant related mortality, relapse, and survival after allogeneic hematopoietic stem cell transplantation for ...
  Magenau J, Pawarode A, Couriel DR, Yanik G, Mineishi S, Braun T, Reddy P, Ferrara JLM, Frame D, Choi SW, Harris AC, Kitko CL, Connelly JA, Levine J, Goldstein SC, American Society of Blood and Marrow Transplantation meeting, 1/1/2013
• The use of early spirometric changes and IGF-1 levels for the detection of patients at risk for BOS.
  Abedin S, Yanik G, Magenau J, Pawarode A, Goldstein SC, Kitko CL, White E, Couriel DR, American Society of Blood and Marrow Transplantation meeting, 1/1/2013
• Exercise and stress management training for patients undergoing autologous or allogeneic hematopoietic cell transplantation. Results from Blood and Marrow Transplant C...
  Lee SJ, Le Rademacher J, Jim H, Syrjala KL, Wingard JR, Logan BR, Wu J, Majhail NS, Wood WA, Rizzo JD, Geller NL, Kitko CL, Faber EA, Abidi MH, Slater SE, Horowitz MM,..., American Society of Hematology Meeting, New Orleans, LA, 1/1/2013
• Biomarkers of extracellular matrix remodeling in chronic GVHD
  Kitko C, Saliba R, Choi S, Reddy P, Goldstein S, Magenau J, Pawarode A, Kennel M, Levine J, White E, Couriel D, European Blood and Marrow Transplant Meeting, London, United Kingdom, 1/1/2013
• A combination of clinical characteristics and day 7 biomarker concentrations predicts graft-versus-host disease following hematopoietic cell transplantation from relat...
  Harris AC, Ferrara JLM, Braun T, Couriel DR, Choi S, Kitko CL, Goldstein SC, Magenau J, Paczesny S, Pawarode A, Reddy P, Yanik G, Taylor A, Connelly JA, Byersdorfer C,..., American Society of Blood and Marrow Transplantation Meeting, Salt Lake City, UT, 1/1/2013
• MIG: a plasma chronic GVHD biomarker that is diagnostic at onset and associated with disease severity
  Kitko C, Couriel D, Levine J, Martin P, Flowers M, Hansen J, Chang L, Braun T, Fox D, Conlon M, Fiema B, Morgan R, Gomez A, Pongtornpipat P, Lamiman K, Storer B, Ferra..., European Blood and Marrow Transplant Meeting, London, United Kingdom, 1/1/2013
• Unrelated donor transplants for older AML patients using a low dose TBI containing regimen are as efficacious as related donor transplants, and exhibit favorable outco...
  Yanik GA, Magenau JM, Mineishi S, Pawarode A, Alangaden K, Peres EM, Goldstein S, Levine JE, Choi S, Kitko CL, Talpaz M, Couriel D, American Society of Hematology Meeting, 1/1/2012
• Hematopoeitic cell transplant (HCT) survivorship: How much variance in depressive symptoms can be accounted for by biomedical variables?
  Kitko C, Zhao L, Carey J, Gourley B, Richard A, Proudfoot S, Mineishi S, Couriel D, Levine JE, Riba M, Hoodin F, American Society of Blood and Marrow Transplantation meeting, 1/1/2012
• Hematopoeitic cell transplant (HCT) survivorship: Does psychological screening make a difference in management of psychological problems?
  Hoodin F, Zhao L, Carey J, Gourley B, Richard A, Proudfoot S, Levine JE, Riba M, Kitko C, Society of Behavioral Medicine meeting, 1/1/2012
• Risk factors for non-relapse mortality in chronic graft versus host disease: Predicting outcomes at disease onset.
  Kitko CL, Saliba RM, Paczesny S, Kennel M, Choi SW, Reddy P, Levine JE, Couriel DR, American Society of Hematology Meeting, 1/1/2012
• Join now to see all

Lectures

• Efficacy of Methoxsalen Sterile Solution in Conjunction with the Therakos¬ Cellex¬ Photopheresis System in Pediatric Patients with Steroid-Refractory Acute GvHD: Inter... 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Highlights from ASH 2014: Pediatric Hematology/Oncology 
  Dearborn, MI - 1/1/2015
• Chronic GVHD Biomarker Discovery: A Pathway to Better Treatments 
  1/1/2014
• Sclerotic and Fibrotic Manifestations of Chronic GVHD 
  San Diego, CA - 1/1/2012
• Pulmonary Complications Following Allogeneic Transplant: Bronchiolitis Obliterans Syndrome and Infections Complications 
  Bangkok, Thailand - 1/1/2012
• Clinical Trials using Extracorporeal Photopheresis for Treatment and Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant 
  Bethesda, MD - 1/1/2012
• Highlights from ASH 2010: Pediatric Hematology/Oncology 
  Dearborn, MI - 1/1/2011
• Coping with the Physical Aspects and Late Effects of Survivorship 
  Troy, MI - 1/1/2010
• Highlights from ASH 2008: Pediatric Hematology/Oncology 
  Dearborn, MI - 1/1/2009
• Extracorporeal Photopheresis for GVHD Therapy: Biology and Clinical Results 
  Denver, CO - 1/1/2008
• Highlights from ASH 2012: Pediatric Hematology/Oncology 
  Dearborn, MI - 1/1/201
• Join now to see all